Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display.

[1]  H. Koga,et al.  Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules. , 2012, The Journal of investigative dermatology.

[2]  D. Siegel,et al.  Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity. , 2010, The Journal of clinical investigation.

[3]  A. Shimizu,et al.  Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation. , 2010, Journal of dermatological science.

[4]  Hayato Takahashi,et al.  Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry from the peripheral blood of patients with pemphigus vulgaris. , 2008, Journal of dermatological science.

[5]  D. Siegel,et al.  Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. , 2008, The Journal of investigative dermatology.

[6]  D. Siegel,et al.  Targeting pemphigus autoantibodies through their heavy-chain variable region genes. , 2007, The Journal of investigative dermatology.

[7]  Jian Ye,et al.  Dissecting the Anti-Desmoglein Autoreactive B Cell Repertoire in Pemphigus Vulgaris Patients1 , 2007, The Journal of Immunology.

[8]  M. Amagai,et al.  Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. , 2006, The Journal of investigative dermatology.

[9]  Masayuki Amagai,et al.  Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. , 2006, The New England journal of medicine.

[10]  B. Thiers.  Genetic and Functional Characterization of Human Pemphigus Vulgaris Monoclonal Autoantibodies Isolated by Phage Display , 2006 .

[11]  Y. Shirakata,et al.  In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. , 2005, The Journal of investigative dermatology.

[12]  Y. Hanakawa,et al.  Enzymatic and Molecular Characteristics of the Efficiency and Specificity of Exfoliative Toxin Cleavage of Desmoglein 1* , 2004, Journal of Biological Chemistry.

[13]  T. Nishikawa,et al.  Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus. , 2003, Journal of the American Academy of Dermatology.

[14]  T. Nishikawa,et al.  Induction of Pemphigus Phenotype by a Mouse Monoclonal Antibody Against the Amino-Terminal Adhesive Interface of Desmoglein 3 1 , 2003, The Journal of Immunology.

[15]  Carlos F. Barbas,et al.  Phage display: a Laboratory manual , 2014 .

[16]  Zhi Hong Wang,et al.  Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 , 2000, Nature Medicine.

[17]  T. Nishikawa,et al.  Human autoantibodies against HD1/plectin in paraneoplastic pemphigus. , 1999, The Journal of investigative dermatology.

[18]  F. Watt,et al.  Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex , 1998 .

[19]  T. Nishikawa,et al.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. , 1998, The Journal of clinical investigation.

[20]  J. Saurat,et al.  Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. , 1998, The Journal of investigative dermatology.

[21]  J. Uitto,et al.  The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. , 1998, The Journal of investigative dermatology.

[22]  Y. Kwon,et al.  cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. , 1997, The Journal of investigative dermatology.

[23]  M. Amagai.  Pemphigus: autoimmunity to epidermal cell adhesion molecules. , 1996, Advances in dermatology.

[24]  T. Nishikawa,et al.  Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. , 1995, The Journal of investigative dermatology.

[25]  M. Amagai,et al.  Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. , 1994, The Journal of investigative dermatology.

[26]  C. Lebbé,et al.  Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. , 1994, The Journal of investigative dermatology.

[27]  M. Peters,et al.  Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia , 1993, Journal of cutaneous pathology.

[28]  J. Stanley.  Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. , 1993, Advances in immunology.

[29]  E. O'Keefe,et al.  Human autoantibodies against desmoplakins in paraneoplastic pemphigus. , 1992, The Journal of clinical investigation.

[30]  Masayuki Amagai,et al.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.

[31]  S. Kim,et al.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia , 1991, The New England journal of medicine.